SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-038013
Filing Date
2022-06-17
Accepted
2022-06-17 17:54:32
Documents
2
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1552
2 POA DOCUMENT poa.txt EX-24 3188
  Complete submission text file 0001209191-22-038013.txt   6125
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-595-2595
Atreca, Inc. (Issuer) CIK: 0001532346 (see all company filings)

IRS No.: 273723255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ATRECA, INC. 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address
Gould Stephen E (Reporting) CIK: 0001934498 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38935 | Film No.: 221025298